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Abstract
Background:  Many studies have been published about giving and receiving bad messages.
However, only a few of them have followed the patients all the way through a disease as is done in
this study. Many studies have been written about patients' coping strategies. In this study we will
keep within the bounds of coping through information only. The aim of the study is to investigate
patients' views of information during the trajectory of their disease, whether their reactions differ
from each other and whether they differ in different phases of the disease.
Methods: Twelve patients with malignant haematological diseases or lung cancer were followed
with interviews from diagnosis to recovery or into the terminal phase or at most for two years.
The method is qualitative, using semi-structured interviews.
Setting: Örebro University Hospital or the patient's home.
Results: All patients described themselves as well informed from the start but in later phases of
their disease some of them came to express a great uncertainty about the progressing disease and
about the approaching death. Most of them, regardless of whether they had a haematological
malignancy or lung cancer, expressed a wish to be well informed all through the disease and even
when the messages were bad. Different strategies for coping with information, however, affected
how they then dealt with the information received. Four such coping strategies were found: 1)
Information-dependent and accepting; 2) Information-dependent but denying; 3) Medically
informed and accepting; 4) Medically informed but denying.
Conclusion: To several patients there was an unmet need for information about the progressing
disease and the approaching death. To optimize the care of these patients it seems important that
the physician is aware of patients' need for information even when the news is bad. Knowing the
patient's information strategy could probably function as a key for the physician to communicate
with patients on these matters.
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Background
Many studies have been published about giving and
receiving bad messages. However, only a few of them have
followed the patients all the way through a disease as is
done in this study. Many studies have been written about
patients' coping strategies since the fundamental work of
Lazarus & Folkman on stress and coping [1]. In this work,
however, we will confine ourselves to coping through
information only, which of course is only a small part of
the coping process as an entity.
Ptacek & Eberhardt [2] reviewed studies published 1985–
1996, studies about the importance of where, when and
how bad messages should be delivered [3-5]. Since 1996
a large number of additional studies have been published
focusing on the disclosure of the diagnosis [6,7] or when
death is coming close [8,9] or the impact of the social and
cultural context for truth-telling [10], and that common
beliefs about what a patient really wants to know could be
misleading [11]. It has also been found that a majority of
patients do wish to be informed even when the messages
are bad [12,13].
Some studies are close to the areas of inquiry of this study,
as when van der Molen [14] stresses information as a key
coping strategy, Quirt et al [15] analyse how patients with
recently diagnosed lung cancer received and held on to
information, Leydon et al [16] and Yardly et al [17]
emphasized the importance of giving moderated and
individualized information. Finally, there is the longitudi-
nal study by The et al [18] of patients with lung cancer,
calling attention to information as a complicated process
of interaction between the physician and the patient.
The chief contribution of this study is that, by following
each patient over time, it becomes possible to notice
changes, if any, in the patient's reaction to information
during the disease. Secondly, this study adds partly new
knowledge, compared to earlier studies, in that it focuses
on and compares coping strategies of two different catego-
ries of patients: patients with malign haematological dis-
eases and those with lung cancer. Thirdly, this study adds
partly new knowledge, compared to earlier studies, in the
way it focuses on patients' need for information all
through the disease.
The aim of the study
The aim of this study is to explore how patients belonging
to two categories of disease relate to information given by
their physicians from diagnosis to cure or until the transi-
tion to terminal care becomes obvious to the patient. The
aims are to investigate patients' view of the information
received:
- regarding the content
- regarding the way the information was given to them
- in the longitudinal perspective, all through the disease,
and as death approaches
- to find out whether the patients' ways of reacting differ
from each other, and if so, how
Methods
The study consists of recurrent interviews with 12 seri-
ously ill patients, 7 patients with malignant haematologi-
cal diseases (acute lymphocytic leukaemia, acute
myelocytic leukaemia, myeloma) and 5 patients with
non-operable lung cancer diseases (adenocarcinoma and
squamous cell cancer). Only 20% of patients diagnosed
with acute leukaemia are estimated to be alive two years
later [19]. Some patients with myeloma get an aggressive
form of the disease bringing them to death within a year,
while others might live with good quality of life for more
than ten years [20]. Among patients with non-small-cell
cancer only 3–7% are alive 5 years later, while 50% die
within 7 months [21].
As the patients were diagnosed at Örebro University Hos-
pital, Sweden, they were consecutively asked to join the
study. Of 11 patients with acute leukaemia or myeloma,
10 were asked and 7 of them accepted. Of 9 patients with
lung cancer, 7 were asked and 5 accepted. Exclusion crite-
ria were if the patient was unable to give informed consent
or understand the questions. The interview period was
2002–2005. The settings were either the hospital or the
patient's home. The total number of interviews was 88,
lasting 5–90 minutes each, all depending on the current
health of the patient. The intention was neither to inter-
view the patients as soon as possible after they had
received their diagnosis nor to follow the patients during
the whole processes of their dying. The first interview was
held from six days to six weeks after the diagnosis had
been given to the patient and the interviews came to an
end as soon as the patients said that they knew that they
were about to die as no more treatment was possible to
stop the progress of the disease.
A summary description of the participants and the
number of interviews is presented in Table 1.
The letters A-G in the following refer to patients with hae-
matological diseases and the letters V-Z to patients with
lung cancer.
Differences in the distribution of interviews
The intention was to interview the patients with haemato-
logical malignancies every fortnight and the patients with
lung cancer as they came for treatment three times
monthly, but for various reasons the number of interviewsBMC Palliative Care 2007, 6:1 http://www.biomedcentral.com/1472-684X/6/1
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came to differ among the patients. Two patients did not
get the desired effect of their treatment and died rather
soon, patient B only four days after the first interview and
patient V after two months. Three patients were excluded
from the study, patient F because she wanted to withdraw,
A for geographical reasons and D as the interview ques-
tions seemed to hurt and upset him. Four patients reached
the desired state of complete remission, but three of these
relapsed and then went on with a second-line treatment.
Only one patient did not relapse at all during the two
years that the patient was followed. Seven patients were
followed into the terminal phase. For the distribution of
interviews, see Table 2.
Ethical considerations
The patients were recruited to the study during their med-
ical visits. As soon as the physicians found it suitable the
patients were given both oral and written information
about the study by their physician. Following Swedish
[22] and international [23] guidelines for medical
research it was stressed that participation was voluntary
and the patients could withdraw whenever they wanted
without any negative consequences for their treatment.
The research ethics committee of Örebro University Hos-
pital approved the study.
Data collection
All interviews, except for those with one patient, were
tape-recorded, conducted and transcribed verbatim by the
first author. During the interviews with the patient who
did not approve of the tape recorder, notes were taken on
the basis of which the interview was reconstructed, which
the patient was given the opportunity to read. The taping
of another three interviews unfortunately failed, due to
technical problems, but notes were taken and a recon-
structed interview was read to the patient (C: 6). The other
times (D: 2, X: 11) the most important questions were
recapitulated in the next interviews held. Each interview
consisted of 5–7 questions. The very first interview fol-
lowed the interview guide, see Additional file 1. Depend-
ing on what the patient said and what happened to the
patient, new questions emerged, see Additional file 2.
Analysis
The study is qualitative, with a hermeneutic approach.
The steps taken in the analysis were inspired by Kvale [24]
and to some extent also by Graneheim and Lundman
[25]. Firstly, all typed material was read through. Then the
material not containing information and messages rele-
vant to the purpose of this study was excluded. The
remaining material was divided into three domains of
investigation: the disclosure of the diagnosis and informa-
tion during the first treatment, during a second treatment,
and terminally. As soon as they were transcribed, all the
taped interviews were listened to once again to assure con-
formity. Then the process of coding started, piece by piece.
During the process of coding, a co-reader checked that the
codes summed up the text passages. Codes with similar
contents, not necessarily confirming each other, were
brought together into different investigation areas. One
such area was how the patient came to deal with the infor-
mation received. Then four possible patterns emerged,
four kinds of strategies for coping with information – the
four categories.
Table 2: The distribution of interviews
Patient Diagnosis/Treatment 1 Treatment 2 Terminally Totally
A3- -3
B1- -1
C922 1 3
D3 - - 3
E631 1 0
F3--3
G1 1- - 1 1
V2-13
W6 - 1 7
X1 12 11 4
Y821 1 1
Z8-19
88
Table 1: Study participants and number of interviews
Category of patient Number of interviews Sex Age
7 Haematologic 44 3 men / 4 women 37-80 years
5 Lung cancer 44 2 men / 3 women 60-71 yearsBMC Palliative Care 2007, 6:1 http://www.biomedcentral.com/1472-684X/6/1
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Results
Patients' views of information
All the patients expressed appreciation for the straightfor-
ward way they had been informed about diagnosis, prog-
nosis, treatment plans, possible side effects,
complications, and a recurrence of the disease. One
patient, though, thought that that she could have been
informed this openly but in a more cautious way. "They
(the physicians) just came by and told me. Was it Christ-
mas Day? Anyhow, one of the days of Christmas ... They
could have told me this more nicely, I think" (X: 1). The
diagnosis was a surprise to everyone, except to patient B.
This patient said: "I did understand. I did know... there is
only the choice of recovery or death" (B: 1). Not all
patients could give the proper name of their diseases, but
they all knew it was either about a malignant haematolog-
ical disease or lung cancer, and without treatment they
would all have been dead within a few weeks or a couple
of months. They had all been informed about the progno-
sis of their disease, yet, one patient made an effort to talk
about the disease as if it was of no such danger to her.
Then she was asked if she knew of anyone who had got the
disease acute leukaemia. She said she did. They had both
died (A: 2, A: 3).
However, four patients out of five with lung cancer got a
sudden, remarkable – but temporary – recovery shortly
after the treatment had started. After this only one of the
patients, and only once more, talked about the incurable-
ness of the disease (X: 8) but as their health started to
decline they all, except patient W, were wondering about
the reasons behind that (Z: 4–8, Y: 5–8, X: 8–13, V: 2).
On the other hand as treatment went on the patients came
to express an adjustment of being in treatment, which
made the fear less for a recurrence of the disease. Now,
they thought that they knew what another treatment
would be like. "If I will relapse, I will relapse... but that
day, that sorrow. It is no big deal if I have to go through it
once more" (C: 9). "I do understand that the cancer could
come again, but I am not worried if I have to go back to
the hospital. Now, I know what it would be like."(E: 6).
Patients' views of the information – when the disease is in 
recurrence
For one of the patients with leukaemia the information
about suddenly declining test results came abruptly and
without warning (C: 10), while for another the relapse
was no surprise at all. This patient had been following the
slowly declining test figures. When the relapse was con-
firmed by a bone marrow test, it was what the patient had
already suspected (E: 9).
To the patients with lung cancer the recurrence of cancer
started in quite a different way. These patients were all hit
by different kinds of diseases, such as thrombosis (Z),
recurrent pneumonia and dyspnoea (Y, X), colds and high
fever (W). This seems to have made it difficult for the
patients to understand when the cancer was in progress
and when not. They all came to express a great uncer-
tainty. "It is like standing at a crossroads, not knowing
which way to go" (Y: 5). Sometimes it happened that they
felt really ill but all the same got good news about the
tumour. "Yes, (they say) the tumour has shrunk! ... I must
say I had expected a little more sad news. I was prepared,
as you can see (pointing at her toilet bag), that they would
keep me here" (Z: 8). Sometimes these patients did ask
their physicians about the cancer. "But he couldn't tell for
sure! I do hope it's not the cancer coming on again!" (X:
12). The patient was then asked whether, if it was the can-
cer coming back, she would have wanted to know about it
or not. The answer was: "Yes I would ... I would ... but,
honestly I don't think he was lying to me ... but he said he
couldn't promise" (X: 12).
Patients' views of the information – in the terminal phase
Two of the patients C and V received the information ver-
bally from their physician that the treatment had failed
and that other treatment was considered to be of no use.
However, patient V had to ask to get this information.
"They don't tell you very much. You have to ask..." (V: 3).
Patient E seemed to have become aware of the transition
to the terminal phase, not from what her physician told
her but mainly because of the declining values of the test
results. The transition to the terminal phase seems in no
way to have been obvious to the patients with lung cancer.
Even when feeling worse they were told, from time to
time, that the tumour had not been growing (Z: 9, Y: 10,
X: 11, W: 4). Not until the very last part of their lives did
the X-rays reveal the progress of the cancer. Patient Y did
not talk about his death as being close and inevitably ter-
minal until only four days before he died (Y: 11). Patient
X said that even if she might not have been given straight
information about the nearness to death, she understood.
"I do not think he has told me so very straight, but he held
my hand and so ... so I did understand what it was all
about" (X:14). Another patient declared that he was all
right only three days before his death. We even talked
about his 70th birthday, which was to come three months
later" (W: 7).
The patients followed into terminal phase were asked if
they had talked with their physicians about death. They
had not. Nor had they talked about when death probably
was to come. Only one had: "They say up to six months or
so, if I'm lucky. Nobody knows, it might be only three" (C:
12). Patient V said: "I ask quite often how long it will take
before I die, but they're not able to answer! I find that very
strange. I would have appreciated if there were some kind
of statistics. I suppose there are, but they don't want to tellBMC Palliative Care 2007, 6:1 http://www.biomedcentral.com/1472-684X/6/1
Page 5 of 8
(page number not for citation purposes)
me" (V: 3). However, even if they had not consulted their
physicians, several of these patients still had an under-
standing of when death was probably about to come,
which turned out to be rather accurate. Only one patient
turned his back on the whole question. He was not in the
least interested in knowing. Death would come, as death
comes to everyone (W: 7).
Patients' strategies for coping with information
Different strategies for coping with information affected
how the patients came to deal with the information
received. Four such coping strategies were found; Infor-
mation-dependent and accepting, Information-depend-
ent but denying, Medically informed and accepting and
Medically informed but denying.
The first type is exemplified by those patients who care-
fully followed every test value of haemoglobin, thrombo-
cytes, neutrophile leukocytes, bone marrow tests, X-rays,
spirometries etc. Their coping strategy is called Informa-
tion-dependent and accepting, and their strategy may be
illustrated by quotations like: "I find everything about this
disease and the treatment of it interesting" (C: 2), or "I
have been asking all the time, first the nurses, and if they
haven't been able to answer I have asked the doctors. I do
want to know what is going on" (C: 8). One of the
patients told her husband every test result, from which he
made statistical diagrams so that they could closely follow
every change in the values (E: 4). These patients continued
to express their need for information all through the dis-
ease, even when the information was sad, and they con-
tinued to follow every test result most carefully. During
second-line treatment, as in the terminal phase, these
patient could, just as before, give the exact figures from the
results of the tests taken (C: 10, C: 11, C: 12, E: 7, E: 9, E:
10).
Patient X illustrates the second coping strategy, Informa-
tion-dependent but denying. Like patients C and E, this
patient wanted information, but then held the informa-
tion back. In the first interview this patient said that she
was informed and that she had understood but now she
tried to repress it all (X: 1). In the following interviews she
often returned to the fact that she did knew, but continued
by saying: "then you have to deceive yourself, you know"
(X: 4). When this patient understood that death was near,
the reaction was: "Well, the thing now is to handle it in a
positive way" (X: 14). When asked what this could mean,
the answer was: "You have to deny it" (X: 14). The patient
held on to this Information-dependent but denying strat-
egy in all phases of the disease.
The third coping strategy is called 'Medically informed
and accepting'. Also these patients appreciated being
informed but they came to deal with the information
received in another way than did the patients categorized
as Information-dependent. While the Information
dependent patient followed every single test result most
carefully, memorizing every value number, the Medically
informed patient never took such an interest in each test
taken. They reckoned that they would be informed when
there was something they ought to know about. "Actually,
you can't keep it all in your head. It's too much" (F: 3).
"I'm not one of those who checks up the test results.
They'll tell me, I suppose, if there's something I should
know" (G: 11). These patients found the focusing on every
test result somewhat tiring and sometimes they were crit-
icising their doctors for being "too medical" or "too
focused" on the test values figures and numbers. "Too
medical ...I was unlucky meeting a real medical doctor, so
to speak" (D: 3). "Yes ... it's a little too technical" (G: 6).
However, of these patients only patient Z was followed
into the terminal phase, so it is hard from this study to tell
how well these patients held on to their strategy. What
was seen in this study was that two of the patients came to
change their strategy slightly to the strategy of denying.
Patient G, after being told that she had been very close to
death, which she had not been aware of (G:9), however,
in the next interview she was back as a non-denying
patient. On the other hand, patient Z became all the more
denying the more her health declined.
The patient using the fourth coping strategy, called Medi-
cally informed but denying, denied the importance of the
information received all through the disease. The patient
approved of being informed: "I want to be informed right
into the middle of my eye" (W: 1) but then he seemed to
take little notice of the information received. "I need not
die because of this. I could die for any reason!" (W: 5).
Yet, this patient said that from the start he not only knew
about the tumour in the lung, but also about the growth
of metastases (W: 7). When asked about how to handle
bad news he answered, as before, that he always wanted
information as straight as possible. Then he was asked if
there had been any bad messages in the physician's infor-
mation today. "No," he answered, "the thing is that there's
no need for any more treatment. It's good as it is ... and I
won't have to visit the hospital until the summer is over"
(Z: 6). The patient died at the beginning of August.
For the categorization of patients' strategies for coping
with information, see Table 3.
Discussion
The point of knowing the patients' strategies for coping to 
bad news
There is a point of knowing the patient's strategy for cop-
ing with information. But it is not in trying to classify
them into any of the four categories found in this study,
as there might be more strategies than those four foundBMC Palliative Care 2007, 6:1 http://www.biomedcentral.com/1472-684X/6/1
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which could perhaps have been discovered if other
patients had been included. The very point of knowing the
patient's strategy for coping with information, we think, is
that the coping strategy could reveal a key to the physician
how to communicate with the patient in difficult matters
such as information about progressing cancer and
approaching death. This is especially true as we found
that, irrespective of coping strategy, the need for informa-
tion remained of great importance all through the disease,
even when life was coming to an end. However, this is not
congruent with the findings of some other studies such as
the one by Leydon et al [26], where it is stated that
patients vary in their attitudes towards information, with
different needs at different times. There is little evidence
for that in this study. We found that information for most
of the patients was of great importance all through the dis-
ease, but that several patients expressed great uncertainty
when life came close to an end.
The number of times participants became interviewed dif-
fered from 1–14. One might then have expected that the
number of interviews could have affected the perceptions
and reactions of the patients' toward their disease, making
a change to the patient's strategy for coping with informa-
tion. As the health of the patients was declining the atti-
tudes to the disease of most patients were changing, but
not their attitudes to information. Only on some occa-
sions did two patients change their strategy to the strategy
of denying. This might also indicate that at least some
patients had the ability to find "a way out", when facts are
too hard to cope with. Otherwise they all hold on to the
strategy they had from start.
One might also have expected that patients with lung can-
cer diseases and haematological diseases would have
reacted somewhat differently to the information given,
revealing differences in when and how much patients
were informed. But we found people who were well
informed and not so well informed in both kinds of
patients, though the less well aware patients were more
often found among patients with lung cancer. The reasons
behind that need to be investigated more.
The age of the interviewees varied, from 37–80 years. The
age could then have been of importance for the strategy of
the patient's but this was not found. The youngest patients
were categorized differently in relation to each other, as
were the oldest patients.
Finally one might have expected gender differences
among the patients' attitudes to information but no such
differences were found.
The finding that patients were well informed from the
start but not in later phases of their disease has been
observed in the literature though different explanations
are given, such as that it is due not only to the information
given by the physicians, but also to the patient's ability to
understand the verbal utterances of the physician, as well
as to the patient's ability to cope with and integrate the
bad news into his or her life [27]. More research is needed
to find out whether the deficiency is due to a lack of infor-
mation by doctors or to a lack of knowledge by patients to
understand the information provided.
How to deal with the lack of knowledge among patients?
The answer to this question will obviously depend on the
reasons behind the lack. Some patients might need further
information, others might need to have the information
explained, or repeated. Still other patients might need to
cope with the information by leaving it behind them.
Improved disclosure and the patients' right to obtain
information about their condition can be supported by
the principle of autonomy [28]. Non-disclosure can be
supported by the principle of beneficence [29]. In the
study by Schapira [30] the tension between those who
favour complete disclosure and those who prefer more
limited truth-telling is confirmed. Both practices, she says,
can be justified ethically and both have received support
in the published literature. We believe that the ethical jus-
Table 3: The categorization of the patients
Patient 1 Information- dependent and accepting 2 Information- dependent but denying 3 Medically informed and accepting 4 Medically informed but denying
A X
B( X )
CX
D X
EX
F X
G X
VX
W X
XX
YX
Z XBMC Palliative Care 2007, 6:1 http://www.biomedcentral.com/1472-684X/6/1
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tification is an act of balancing the pros and cons for what
seems to be the best for the patient. But it has to be
emphasized what is found in many studies and confirmed
in this one is that most patients want to be well informed
even when the messages are bad.
To optimize care of patients it seems important that, irre-
spective of the reason behind the lack of knowledge
among patients, it is recognized and as much as possible
minimized by their physician. We believe that a patient
with a better knowledge about approaching death is more
able to make the necessary and desired practical, eco-
nomic, social and spiritual adjustments and preparations
in time before his or her death. Talking about death could
probably harm some patients, at least in the short term,
but if patients are as information-dependent as shown in
this study and if the physicians are good at telling even sad
news, as reflected in the interviews of this study, we are
convinced that most patients would be relieved.
Limitations, trustworthiness and validity
In this study the first author had the unique opportunity
to follow two groups of patients with severe disease over
time. The patients, however, were not interviewed during
the first shocking phase after having received their diagno-
sis. This might have affected the patients, so that they had
a more positive attitude from the start, that is, to the infor-
mation received, to the way it was given to them and to
the informing physician.
As already noted only seven out of twelve patients, for var-
ious reasons, were followed into the terminal phase (see
Table 2).
The intention to maintain some regularity in following
the patients could not always be realized. Some prear-
ranged interviews had to be shorted in time or postponed
for days, or even weeks, because of the patient's actual
state of health.
A final important point is that not all patients' strategies
for coping with information were easy to identify. The
patients in categories 1 and 4 were easy to identify, but not
patients in categories 2 and 3. How to categorize these
patients was very much a question of what to emphasize.
By balancing the patients from one category to another, it
became obvious where the patients fitted best.
Of course, the interview material can also be criticized for
not being reproducible, as each interview reflects what the
patients remembered about the past in a fleeting moment
when they were met [31]. However, each interview is a
valuable source of information even if the results cannot
be generalized. The methodology is chosen to be appro-
priate for the questions formulated [32]. The intention
was to follow as closely as possible the words of the
patients, but there is always the possibility of misinterpre-
tations or over-interpretations. To minimize such risks
most interviews started with a short recapitulation of the
previous one held. Checking questions were also used
(dialogic validity) [33]. Finally, all through the study, crit-
ical researchers, physicians and co-readers have critically
read and checked the interpretations made (communica-
tive validity) [34].
Conclusion
The result of this study could help to improve health care,
if it could make physicians
- more aware of the fact that there are patients whose need
for information remains of great importance all through
the disease, even in later phases and when life comes near
to the end
- more aware that there is sometimes a lack of knowledge
among patients, to be recognized and as much as possible
minimized
- more aware that knowing the patient's strategy for cop-
ing with information could probably function as a key for
the physician when to communicate with the patient
about progressing disease and about death coming near
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